Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 06, 2020

BUY
$0.43 - $0.75 $0 - $0
1 Added 0.01%
20,001 $11,000
Q2 2018

Aug 06, 2018

SELL
$1.16 - $2.0 $439 - $758
-379 Reduced 1.86%
20,000 $28,000
Q1 2018

May 15, 2018

BUY
$1.6 - $3.17 $32,606 - $64,601
20,379 New
20,379 $36,000

Others Institutions Holding OGEN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About ORAGENICS INC


  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $41.9M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.